Welcome Eva Libaers to the team!
Today, Eva Libaers has joined our team as a new lab technician. She recently graduated with a Bachelor’s Degree in Biomedical Laboratory Technology.
Tine presenting her oncolytic virotherapy research at International Oncolytic Virotherapy Conference in Banff.
A PhD student in our lab, Tine, attended the International Oncolytic Virotherapy Conference in Banff where she presented her work on oncolytic virotherapy as a treatment for glioblastoma.
This conference features renowned speakers from around the world who share their recent developments in oncolytic virotherapy from a scientific, clinical and industry perspective
Brecht Permentier joins the team as a new PhD student.
After doing his Master’s thesis in the Daelemans lab and graduating as a Bioscience engineer, Brecht will join our team as a fresh PhD student focusing on the target identification of novel anticancer drugs.
Teambuilding Daelemans Lab summer 2023.
Today, the Daelemans Lab went on a canoe trip through the city of Leuven. In the evening, we ended the day with a nice dinner.
Identification of TMEM106B as a receptor mediating ACE2-independent SARS-CoV-2 cell entry.
Our research lab has recently identified TMEM106B from a CRISPR-KO screen. Following this, we characterized TMEM106B and learned its function as a receptor mediating ACE2-independent SARS-CoV-2 cell entry. This research has been published in Cell.